SMTL ID : 7ama.1

IL-17A in complex with small molecule modulators

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.48 Å

Oligo State

homo-dimer

Ligands

1 x RMK: ~{N}-[(2~{S})-1,1-dicyclopropyl-3-[[4-(3,5-dimethyl-1~{H}-pyrazol-4-yl)phenyl]amino]-3-oxidanylidene-propan-2-yl]-2-propan-2-yl-pyrazole-3-carboxamide(Non-covalent)

RMK.1: 18 residues within 4Å: Chain A: P.45, I.48, Q.76, E.77, I.78, L.79, V.80, L.81 Chain B: Y.44, P.45, V.47, I.48, W.49, Q.76, E.77, I.78, L.79, V.99 16 PLIP interactions: 9 interactions with chain B, 7 interactions with chain A Hydrophobic interactions: B:P.45, B:I.48, B:I.78, B:I.78, B:L.79, B:V.99, A:P.45, A:I.78, A:I.78, A:V.80, A:L.81 Hydrogen bonds: B:W.49, B:L.79, B:L.79, A:L.79, A:L.79

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Andrews, M.D. et al., Discovery of an Oral, Rule of 5 Compliant, Interleukin 17A Protein-Protein Interaction Modulator for the Potential Treatment of Psoriasis and Other Inflammatory Diseases. J.Med.Chem. (2022)

Release Date

2022-04-20

Peptides

Interleukin-17A: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Interleukin-17A

Related Entries With Identical Sequence